Repare Therapeutics appoints CFO as new CEO

Repare Therapeutics ( NASDAQ: RPTX ) announced that Steve Forte, executive vice president and chief financial officer, has been appointed as president and chief executive officer and to the board effective April 11, 2025. Forte will serve as CEO in addition to his current role.